These are questions I’ll be asking my guest, Thomas C. Gerber, M.D., Ph.D., a preventive cardiologist from the Department of Cardiovascular Diseases at the Mayo Clinic as discuss “Pharmacologic Options to Maintain a Healthy Heart.” For more information on heart health, check out Mayo Cl...
After rolling out this summer, the drug fell short in the fourth quarter of 2015, bringing in just $5 million. But the Swiss pharma giant says things are about to heat up, and it plans to make that happen with an expanded, retrained sales force that'll be targeting mainly cardiologists....